Clinical evaluation of indoramin, a new antihypertensive agent P. J. LewisC. F. GeorgeC. T. Dollery Originals Pages: 211 - 216
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken®) I. PerssonJ. Ulrich Originals Pages: 217 - 219
Renal effects of bumetanide, a new saluretic agent S. -G. KarlanderR. HenningO. Lundvall Originals Pages: 220 - 223
Evaluation in man of bumetanide, a new diuretic agent R. HenningO. Lundvall Originals Pages: 224 - 227
Plasma dopamine-β-hydroxylase activity as a measure of sympathetic activity during halothane anaesthesia in children G. PlanzE. YilmazD. Palm Originals Pages: 228 - 233
Disappearance from the newborn of circulating prenatally administered phenobarbital B. JallingL. O. BoréusS. Agurell Originals Pages: 234 - 238
Serum quinidine levels after administration of three different quinidine preparations R. HenningG. Nyberg Originals Pages: 239 - 244
Plasma levels of procaine amide after administration of conventional and sustained-release tablets E. Karlsson Originals Pages: 245 - 250
A new sustained-release tablet formulation of procainamide D. FremstadS. DahlK. H. Landmark Originals Pages: 251 - 255
Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man L. M. FuccellaG. C. GoldanigaG. Valzelli Originals Pages: 256 - 260
Evaluation of alclofenac treatment regimes in man M. Strolin BenedettiP. StrolinC. Nagant de Deuxchaisnes Originals Pages: 261 - 267
Determination of nanogram quantities of diphenhydramine and orphenadrine in human plasma using gas-liquid chromatography W. BilzerU. Gundert-Remy Originals Pages: 268 - 270
